News

Sharing on social networks

IranPharmis Participates in the 10th Iranian Wound and Tissue Repair Congress 2023 – Showcasing Innovation in Wound Care

IranPharmis unveiled its latest wound care solutions — including the launch of “Zetuvit Silicone” — highlighting innovation and scientific collaboration at one of Iran’s most prominent medical congresses.
IranPharmis Participates in the 10th Iranian Wound and Tissue Repair Congress 2023 – Showcasing Innovation in Wound Care
The 10th Iranian Congress on Wound Healing and Tissue Repair was held from November 29 to December 1, 2023, at Shahid Beheshti University of Medical Sciences.
IranPharmis participated actively in this national scientific event to introduce its latest achievements in wound management and tissue repair. The company’s presence — marked by the unveiling of Zetuvit Silicone — emphasized its ongoing commitment to innovation, quality, and advancing healthcare outcomes in Iran


The “10th Iranian Congress on Wound Healing and Tissue Repair” was held from November 29 to December 1, 2023, at “Shahid Beheshti University of Medical Sciences”.

Recognized as one of the most prominent national scientific gatherings in the field of wound management and tissue regeneration, this event provided a valuable platform for knowledge exchange among specialists, university professors, and medical equipment companies.

 IranPharmis, as one of the leading brands in the country’s medical device industry, participated actively in this congress with the goal of introducing its latest products and innovative wound care solutions. The company played a significant role in fostering scientific engagement and showcasing modern technologies that contribute to improved patient care.

 

Why IranPharmis Participated

IranPharmis’ presence at the congress was driven by its mission to present innovative technologies for wound management, exchange specialized knowledge with physicians, and enhance patient care standards across healthcare facilities.

Relying on a scientific approach, a commitment to quality, and a focus on effective therapeutic development, the company continually strives to make a meaningful contribution to accelerating wound healing and improving patients’ quality of life through the adoption of modern technologies.

 

Activities and Achievements of IranPharmis

Throughout the three-day congress, IranPharmis implemented a range of specialized activities designed to highlight its expertise and product innovations:

  •        Participation in scientific panels and expert sessions focused on addressing key challenges in wound care and tissue repair.
  •       Providing technical and educational consultations on the optimal use of dressings and wound care products.
  •       Engaging directly with physicians and nurses to better understand clinical needs and share up-to-date treatment solutions.
  •       Distributing educational brochures and introducing newly developed products aimed at enhancing the effectiveness of wound management.

 

Product Launch: Zetuvit Silicone

A major highlight of IranPharmis’ participation was the official unveiling of its new product, “Zetuvit Silicone.”

This advanced wound dressing received an enthusiastic response from specialists and attendees for its innovative design and patient-centered functionality.

Zetuvit Silicone has been developed using soft silicone technology to maximize patient comfort, accelerate wound healing, and minimize pain during dressing changes.

 

Key Features of Zetuvit Silicone:

  •       Controlled adhesion that protects the skin and prevents trauma during dressing removal — ideal for both acute and chronic wounds
  •       Enhanced healing performance by maintaining an optimal moisture balance at the wound site.
  •       Ease of use and ergonomic design, tailored to meet the practical needs of wound care professionals.

The introduction of “Zetuvit Silicone” reflects IranPharmis’ steadfast commitment to innovation, product excellence, and responsiveness to real clinical needs. This product marks a significant milestone in advancing the standards of wound care within Iran’s healthcare system.

 

Professional Engagement and Feedback

During the congress, IranPharmis established direct communication with a wide range of dermatologists, wound care nurses, and hospital managers.

These scientific interactions provided valuable opportunities for understanding specialized clinical requirements and exchanging professional experiences.

The feedback received during the event offered critical insights that will guide the company’s research and development teams in the continuous improvement of product design and innovation.

 

Future Outlook and Conclusion

Participation in the “10th Iranian Congress on Wound Healing and Tissue Repair” once again reaffirmed IranPharmis’ scientific leadership and professional standing in the country’s medical device industry

Looking ahead, the company will continue to focus on:

  •        Developing new and effective products in the field of wound healing and tissue regeneration.
  •       Expanding scientific collaborations with healthcare institutions and academic centers.
  •       Enhancing service quality and improving nationwide access to standard, high-quality medical equipment.

Through these continued efforts, IranPharmis remains dedicated to raising the standard of wound care, supporting healthcare professionals, and improving patient outcomes across Iran.

for more acquaintance with the specialized solutions in the field of medical equipment , please visit the product page in our website.

 


Dec 1, 2023 09:32
Number of visit : 106
End of news

Comments

Sender name is required
Email is required
Characters left: 500
Comment is required